Official Journal of Research Center for Gastroenterology and Liver Diseases
e-ISSN 1735-3408
p-ISSN 1735-143X
Citation data
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
11 resultsUpdated October 28, 2026
1
Prevalence and clinical characteristics of concurrent chronic hepatitis B and fatty liver disease in China: a systematic review and meta-analysis
BMC Public Health
December 2026
Huang J.
2
The Effects of Combined Training along with Royal Jelly on Body Composition and Fatty Liver Indices in Postmenopausal Women: A Quasi-Experimental Study
Iranian Journal of Obstetrics Gynecology and Infertility
September 2025
Mazharimajd Z.
3
4
Recent Progresses on Pathophysiology, Diagnosis, Therapeutic Modalities, and Management of Non-alcoholic Fatty Liver Disorder
Current Drug Therapy
2024
Barazesh M.
5
Risk Factors of Non-alcoholic Fatty Liver Disease in the Iranian Adult Population: A Systematic Review and Meta-analysis
Hepatitis Monthly
Dec 2023
Amini-Salehi E.
6
Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis
Clinical and Experimental Pharmacology and Physiology
May 2023
Musazadeh V.
7
Prevalence of non-alcoholic fatty liver and its related factors in Iran: Systematic review and meta-analysis
Journal of Education and Health Promotion
1 January 2023
Chegeni M.
8
The Prevalence of Non-Alcoholic Fatty Liver Disease in Iranian Children and Adult Population: A Systematic Review and Meta-Analysis
Iranian Journal of Public Health
2023
Hassanipour S.
9
Relationship Between Cardiovascular Disease Risk Factors and Quality of Life in Patients with Metabolic-Associated Fatty Liver Disease
Hepatitis Monthly
1 December 2022
Jamali R.
10
Educational Intervention in Promoting Fatty Liver Preventive Behaviors in Women: Using the Protection Motivation Theory
Journal of Education and Community Health
September 2022
Sharifi N.
11
The effect of nigella sativa supplementation on cardiometabolic outcomes in patients with non-alcoholic fatty liver: A randomized double-blind, placebo-controlled trial
Complementary Therapies in Clinical Practice
August 2022
Rashidmayvan M.